Möchten Sie immer auf dem neuesten Stand bleiben?

Real-world data advances new insights into donor selection, benchmarks for patient infection prevention and comparative outcomes in a modern post-transplant cyclophosphamide (PTCy) era MINNEAPOLIS,...

NMDP celebrates bipartisan Senate introduction of life-saving Blood Stem Cell Therapeutic and Research Reauthorization Act.

NMDP recently hired Ginna Laport, M.D., as senior vice president, strategic, scientific and clinical partnerships.

ACCESS trial results at the 2026 Tandem Meetings reinforce mismatched unrelated donors as safe, effective and well-tolerated option Practice-advancing research conducted through CIBMTR demonstrates...

Big Nova has made a $3 million philanthropic gift to NMDP that will support thousands of patients receiving life-saving cell therapy.

NMDP, a global nonprofit leader in cell therapy, recently welcomed Jessica Kowal as chief philanthropy officer.

NMDP launched a new PSA called "Know Your N-M-D-Ps,” featuring a puppet rock star, to raise awareness of blood stem cell transplants.

NMDP℠ announced that is has exceeded its $100 million comprehensive campaign goal to remove financial barriers for patients and accelerate research.

NMDP named as a top workplace, notching 4th place in the 'extra large' company category of 2025 Best Places to Work.

NMDP℠ invites communities nationwide to join NMDP Unite: a community celebration to find cures and save lives on Sept. 20, 2025, World Marrow Donor Day.